DoW Tuberous Sclerosis Complex, Idea Development Award
Agency: Defense Health Agency Contracting Activity - DHACA
- 12.420 -- Military Medical Research and Development
Archived opportunityLast Updated: May 13, 2026
Important dates
- Archived: September 5, 2026
- Closed: August 6, 2026
Award details
- Expected project funding: $3,200,000
- Expected awards: 4
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:HT942526TSCRPIDA
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Science technology and other research and development
- Category Explanation:Not specified
History
- Posted date: May 5, 2026
- Archive date: September 5, 2026
- Version: 1
Summary
Jump to documentsSummary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award (IDA) supports conceptually innovative and high-impact research that could ultimately lead to critical discoveries in tuberous sclerosis complex (TSC) research and/or improvements in patient care.
Distinctive Features: This funding mechanism allows for established and new-to-the-field investigators. New-to-the-field investigators are independent investigators that are early in their faculty appointments and/or established investigators transitioned from other research fields into TSC research. Applications to the New-to-the-Field option will compete separately from the Established Investigators submitting to the regular Idea Development Award (IDA).
Eligibility
Miscellaneous
- Unrestricted
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526TSCRPIDA_GG.pdf | FY26 TSCRP IDA Program Announcement | May 8, 2026 10:56 AM UTC |
Agency contact information
Email: help@eBRAP.org
CDMRP Help Desk
Link to additional information
No additional information is available
